3.84

5.79% 0.21

After Hours: 3.87 0.03 +0.78%

Rezolute Inc (RZLT)

Overview News Price History Financials Discussions Forecast Stock Split

Rezolute Inc stock is traded at $3.84, with a volume of 6.33M. It is up +5.79% in the last 24 hours and up +54.84% over the past month. Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Previous Close:

$3.63

Open:

$3.61

24h Volume:

6.33M

Relative Volume:

0.94

Market Cap:

$356.07M

Revenue:

Net Income/Loss:

$-69.31M

P/E Ratio:

-3.0236

EPS:

-1.27

Net Cash Flow:

$-62.80M

1W Performance:

+23.08%

1M Performance:

+54.84%

6M Performance:

-40.65%

1Y Performance:

-20.17%

1-Day Range:

$3.58

$4.09

1-Week Range:

$2.9537

$4.09

52-Week Range:

$1.07

$11.46

Rezolute Inc Stock (RZLT) Company Profile

Name

Rezolute Inc

Sector

Healthcare (1111)

Industry

Biotechnology (622)

Phone

650-206-4507

Address

275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY

Employee

Twitter

Next Earnings Date

2025-09-17

Latest SEC Filings

RZLT's Discussions on Twitter

Compare RZLT vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RZLT Rezolute Inc	3.84	336.60M	0	-69.31M	-62.80M	-1.27
VRTX Vertex Pharmaceuticals Inc	491.47	117.98B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	803.17	82.85B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	821.96	51.58B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	314.40	40.75B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	346.07	38.33B	4.98B	69.60M	525.67M	0.5198

Rezolute Inc Stock (RZLT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-11-25	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Dec-11-25	Downgrade	Craig Hallum	Buy → Hold
Dec-11-25	Downgrade	Wedbush	Outperform → Neutral
Nov-05-24	Initiated	Wedbush	Outperform
Aug-27-24	Initiated	Guggenheim	Buy
Jul-17-24	Initiated	BTIG Research	Buy
Jun-04-24	Initiated	Craig Hallum	Buy
Apr-09-24	Initiated	Maxim Group	Buy
Aug-02-22	Resumed	Canaccord Genuity	Buy
Jun-15-22	Initiated	Cantor Fitzgerald	Overweight
Sep-08-21	Initiated	ROTH Capital	Buy
May-27-21	Initiated	Oppenheimer	Outperform
May-25-21	Initiated	H.C. Wainwright	Buy

View All

Rezolute Inc Stock (RZLT) Latest News

Feb 16, 2026

Q1 Earnings Estimate for Rezolute Issued By HC Wainwright - MarketBeat

Feb 16, 2026

Feb 15, 2026

Will Rezolute Inc. benefit from rate cutsEarnings Summary Report & Consistent Profit Focused Trading Strategies - mfd.ru

Feb 15, 2026

RZLT SECURITIES ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - marketscreener.com

Feb 15, 2026

Feb 14, 2026

How Rezolute Inc. stock reacts to global recession fearsJuly 2025 Price Swings & Stepwise Swing Trade Plans - mfd.ru

Feb 14, 2026

Biotech Company Advances Breakthrough Hyperinsulinism Treatment - streetwisereports.com

Feb 14, 2026

Feb 13, 2026

Rezolute Reports Q2 Loss, Downgrades Ahead - Intellectia AI

Feb 13, 2026

INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - PR Newswire

Feb 13, 2026

Feb 12, 2026

Is Rezolute Inc. a top pick in the sectorWeekly Investment Recap & High Return Stock Watch Alerts - mfd.ru

Feb 12, 2026

Is Rezolute Inc. benefiting from interest rate changesWeekly Trade Summary & Long-Term Safe Investment Ideas - mfd.ru

Feb 12, 2026

Rezolute (NASDAQ:RZLT) Announces Quarterly Earnings Results - MarketBeat

Feb 12, 2026

Rezolute (RZLT) Reports Decline in Cash Reserves by Year-End - GuruFocus

Feb 12, 2026

Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - The Manila Times

Feb 12, 2026

Press Release: Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - 富途牛牛

Feb 12, 2026

Feb 11, 2026

Is Rezolute Inc. backed by strong institutional buyingTrade Exit Report & Short-Term Swing Trade Alerts - mfd.ru

Feb 11, 2026

Can Rezolute Inc. navigate macro headwindsInflation Watch & Proven Capital Preservation Tips - mfd.ru

Feb 11, 2026

Feb 09, 2026